Search results
Showing 31 to 45 of 47 results for uterine fibroid
This guideline covers identifying children, young people and adults with symptoms that could be caused by cancer. It outlines appropriate investigations in primary care, and selection of people to refer for a specialist opinion. It aims to help people understand what to expect if they have symptoms that may suggest cancer.
Show all sections
Sections for NG12
This guideline covers the care of pregnant women and pregnant trans and non-binary people and their babies during labour and immediately after birth. It focuses on women and pregnant people who give birth between 37 and 42 weeks of pregnancy (‘term’). The guideline helps women and pregnant people to make informed choices about where to have their baby and about their care in labour. It also aims to reduce variation in aspects of care.
View recommendations for NG235Show all sections
Sections for NG235
- Overview
- Recommendations
- Recommendations for research
- Rationale and impact
- Context
- Appendix A: Adverse outcomes for different places of birth
- Appendix B: Outcomes for different places of birth – by BMI at booking
- Appendix C: Outcomes for intravenous remifentanil patient-controlled analgesia (PCA) compared with intramuscular pethidine
Ectopic pregnancy and miscarriage: diagnosis and initial management (NG126)
This guideline covers diagnosing and managing ectopic pregnancy and miscarriage in women with complications, such as pain and bleeding, in early pregnancy (that is, up to 13 completed weeks of pregnancy). It aims to improve how early pregnancy loss is diagnosed, and the support women are given, to limit the psychological impact of their loss.
Hysteroscopic morcellation of uterine leiomyomas (fibroids) (IPG522)
This guidance has been updated and replaced by NICE interventional procedures guidance 704.
This guidance has been updated and replaced by NICE interventional procedures guidance 522.
This guidance has been updated and replaced by NICE HealthTech guidance 240.
Interventional procedures, IPG367 - Issued: November 2010 --> We have moved interventional procedures guidance 367 to become HealthTech guidance 240. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
This guidance has been updated and replaced by NICE HealthTech guidance 240.
Laparoscopic removal of uterine fibroids with power morcellation (IPG703)
We have moved interventional procedures guidance 703 to become HealthTech guidance 589. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids (IPG689)
We have moved interventional procedures guidance 689 to become HealthTech guidance 572. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Hysteroscopic mechanical tissue removal (hysteroscopic morcellation) for uterine fibroids (IPG704)
We have moved interventional procedures guidance 704 to become HealthTech guidance 590. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids (IPG413)
Interventional procedures, IPG413 - Issued: November 2011 --> We have moved interventional procedures guidance 413 to become HealthTech guidance 277. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids (IPG231)
This guidance has been updated and replaced by NICE HealthTech guidance 277.
Magnetic resonance (MR) image-guided percutaneous laser ablation of uterine fibroids (IPG30)
We have moved interventional procedures guidance 30 to become HealthTech guidance 12. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.
We have moved interventional procedures guidance 657 to become HealthTech guidance 523. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.